Nosology and Pathology of Langerhans Cell Histiocytosis

Hematology/Oncology Clinics of North America

Volumn 29, Issue 5, 2015, Pages 799-823

  Picarsic, Jennifer ^a   Jaffe, Ronald ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Congenital and acquired disorders; Erdheim Chester disease; Juvenile xanthogranuloma; Langerhans cell histocytosis; Rosai Dorfman disease

Indexed keywords

B RAF KINASE; LANGERIN; PROTEIN S 100; T6 ANTIGEN;

BONE LESION; BONE MARROW; BRAF GENE; CENTRAL NERVOUS SYSTEM; DISEASE CLASSIFICATION; ERDHEIM CHESTER DISEASE; GASTROINTESTINAL TRACT; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HYPOTHYROIDISM; IMMUNOPHENOTYPING; JUVENILE XANTHOGRANULOMA; LANGERHANS CELL HISTIOCYTOSIS; LIVER HYPERTROPHY; LUNG DISEASE; LYMPH NODE; PRIORITY JOURNAL; REVIEW; SINUS HISTIOCYTOSIS; SKIN MANIFESTATION; SPLENOMEGALY; THYMUS; HISTIOCYTOSIS, LANGERHANS-CELL; PATHOLOGY;

HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS;

EID: 84942319855     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2015.06.001     Document Type: Review

References (94)

1. Hervier B., Haroche J., Arnaud L., et al. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation: a multicenter study of 23 cases. Blood 2014, 124(7):1119-1126.
2. O'Malley D.P., Duong A., Barry T.S., et al. Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases. Mod Pathol 2010, 23(12):1616-1623.
3. Abla O., Halliday W., Laughlin S., et al. Central nervous system juvenile xanthogranuloma after Langerhans cell histiocytosis. Pediatr Blood Cancer 2013, 60(2):342-343.
4. Bains A., Parham D.M. Langerhans cell histiocytosis preceding the development of juvenile xanthogranuloma: a case and review of recent developments. Pediatr Dev Pathol 2011, 14(6):480-484.
5. Rezk S.A., Spagnolo D.V., Brynes R.K., et al. Indeterminate cell tumor: a rare dendritic neoplasm. Am J Surg Pathol 2008, 32(12):1868-1876.
6. Chan J.K., Lamant L., Algar E., et al. ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood 2008, 112(7):2965-2968.
7. Badalian-Very G., Vergilio J.A., Degar B.A., et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 2010, 116(11):1919-1923.
8. Berres M.L., Lim K.P., Peters T., et al. BRAF V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med 2014, 211(4):669-683.
9. Lau S.K., Chu P.G., Weiss L.M. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol 2008, 32(4):615-619.
10. Chikwava K., Jaffe R. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Pediatr Dev Pathol 2004, 7(6):607-614.
11. Jaffe R., Chikwava K. Disorders of histiocytes. Hematopathology 2012, 577. Elsevier Saunders, Philadelphia. 2nd edition. E.D. Hsi (Ed.).
12. Ernemann U., Skalej M., Hermisson M., et al. Primary cerebral non-Langerhans cell histiocytosis: MRI and differential diagnosis. Neuroradiology 2002, 44(9):759-763.
13. Maric I., Pittaluga S., Dale J.K., et al. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 2005, 29(7):903-911.
14. Maia D.M., Dorfman R.F. Focal changes of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) associated with nodular lymphocyte predominant Hodgkin's disease. Hum Pathol 1995, 26(12):1378-1382.
15. Delacretaz F., Meuge-Moraw C., Anwar D., et al. Sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman disease) in an HIV-positive patient. Virchows Arch A Pathol Anat Histopathol 1991, 419(3):251-254.
16. Menon M.P., Evbuomwan M.O., Rosai J., et al. A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease?. Histopathology 2014, 64(3):455-459.
17. Rossbach H.C., Dalence C., Wynn T., et al. Faisalabad histiocytosis mimics Rosai-Dorfman disease: brothers with lymphadenopathy, intrauterine fractures, short stature, and sensorineural deafness. Pediatr Blood Cancer 2006, 47(5):629-632.
18. Haupt R., Minkov M., Astigarraga I., et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer 2013, 60(2):175-184.
19. Roncaroli F., Consales A., Galassi E., et al. Occipital aneurysmal bone cyst secondary to eosinophilic granuloma. Pediatr Neurosurg 2001, 35(2):103-106.
20. Strehl J.D., Stachel K.D., Hartmann A., et al. Juvenile xanthogranuloma developing after treatment of Langerhans cell histiocytosis: case report and literature review. Int J Clin Exp Pathol 2012, 5(7):720-725.
21. Haroche J., Charlotte F., Arnaud L., et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood 2012, 120(13):2700-2703.
22. Hashimoto K., Bale G.F., Hawkins H.K., et al. Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker type). Int J Dermatol 1986, 25(8):516-523.
23. Mandel V.D., Ferrari C., Cesinaro A.M., et al. Congenital "self-healing" Langerhans cell histiocytosis (Hashimoto-Pritzker disease): a report of two cases with the same cutaneous manifestations but different clinical course. J Dermatol 2014, 41(12):1098-1101.
24. Jaffe R. Is there a role for histopathology in predicting the clinical outcome in congenital and infant Langerhans cell disease?. Pediatr Blood Cancer 2009, 53(6):924-925.
25. Varga E., Korom I., Polyanka H., et al. BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis. J Eur Acad Dermatol Venereol 2014, 29(6):1205-1211.
26. Edelbroek J.R., Vermeer M.H., Jansen P.M., et al. Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancy. Br J Dermatol 2012, 167(6):1287-1294.
27. Ozono S., Inada H., Nakagawa S., et al. Juvenile myelomonocytic leukemia characterized by cutaneous lesion containing Langerhans cell histiocytosis-like cells. Int J Hematol 2011, 93(3):389-393.
28. Skinner M., Briant M., Morgan M.B. Erdheim-Chester disease: a histiocytic disorder more than skin deep. Am J Dermatopathol 2011, 33(2):e24-e26.
29. Thawerani H., Sanchez R.L., Rosai J., et al. The cutaneous manifestations of sinus histiocytosis with massive lymphadenopathy. Arch Dermatol 1978, 114(2):191-197.
30. Frater J.L., Maddox J.S., Obadiah J.M., et al. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case. J Cutan Med Surg 2006, 10(6):281-290.
31. Wang K.H., Chen W.Y., Liu H.N., et al. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients. Br J Dermatol 2006, 154(2):277-286.
32. Favara B.E., Steele A. Langerhans cell histiocytosis of lymph nodes: a morphological assessment of 43 biopsies. Pediatr Pathol Lab Med 1997, 17(5):769-787.
33. Edelweiss M., Medeiros L.J., Suster S., et al. Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases. Hum Pathol 2007, 38(10):1463-1469.
34. Favara B.E., Jaffe R., Egeler R.M. Macrophage activation and hemophagocytic syndrome in Langerhans cell histiocytosis: report of 30 cases. Pediatr Dev Pathol 2002, 5(2):130-140.
35. Schmitz L., Favara B.E. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998, 12(2):221-246.
36. Ronceray L., Potschger U., Janka G., et al. Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome. J Pediatr 2012, 161(1):129-133.e1-3.
37. Minkov M., Potschger U., Grois N., et al. Bone marrow assessment in Langerhans cell histiocytosis. Pediatr Blood Cancer 2007, 49(5):694-698.
38. Shin S.S., Sheibani K., Kezirian J., et al. Immunoarchitecture of normal human bone marrow: a study of frozen and fixed tissue sections. Hum Pathol 1992, 23(6):686-694.
39. Galluzzo M.L., Braier J., Rosenzweig S.D., et al. Bone marrow findings at diagnosis in patients with multisystem Langerhans cell histiocytosis. Pediatr Dev Pathol 2010, 13(2):101-106.
40. Chantranuwat C. Systemic form of juvenile xanthogranuloma: report of a case with liver and bone marrow involvement. Pediatr Dev Pathol 2004, 7(6):646-648.
41. Kesserwan C., Boue D.R., Kahwash S.B. Isolated juvenile xanthogranuloma in the bone marrow: report of a case and review of the literature. Pediatr Dev Pathol 2007, 10(2):161-164.
42. Christiansen E.C., Ellwein M., Neglia J.P. Splenomegaly unresponsive to standard and salvage chemotherapy in Langerhans cell histiocytosis: a case of extramedullary hematopoiesis. Pediatr Blood Cancer 2012, 58(6):998-999.
43. Dehner L.P. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 2003, 27(5):579-593.
44. Kaplan K.J., Goodman Z.D., Ishak K.G. Liver involvement in Langerhans' cell histiocytosis: a study of nine cases. Mod Pathol 1999, 12(4):370-378.
45. Favara B.E. Histopathology of the liver in histiocytosis syndromes. Pediatr Pathol Lab Med 1996, 16(3):413-433.
46. Meyer J.S., De Camargo B. The role of radiology in the diagnosis and follow-up of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998, 12(2):307-326.
47. Jaffe R. Liver involvement in the histiocytic disorders of childhood. Pediatr Dev Pathol 2004, 7(3):214-225.
48. Hadzic N., Pritchard J., Webb D., et al. Recurrence of Langerhans cell histiocytosis in the graft after pediatric liver transplantation. Transplantation 2000, 70(5):815-819.
49. Honda R., Ohno Y., Iwasaki T., et al. Langerhans' cell histiocytosis after living donor liver transplantation: report of a case. Liver Transpl 2005, 11(11):1435-1438.
50. Picarsic J., Egeler R.M., Chikwava K., et al. Histologic patterns of thymic involvement in Langerhans cell proliferations: a clinicopathologic study and review of the literature. Pediatr Dev Pathol 2015, 18(2):127-138.
51. Gilcrease M.Z., Rajan B., Ostrowski M.L., et al. Localized thymic Langerhans' cell histiocytosis and its relationship with myasthenia gravis. Immunohistochemical, ultrastructural, and cytometric studies. Arch Pathol Lab Med 1997, 121(2):134-138.
52. Lakatos K., Herbruggen H., Potschger U., et al. Radiological features of thymic Langerhans cell histiocytosis. Pediatr Blood Cancer 2013, 60(11):E143-E145.
53. Ducassou S., Seyrig F., Thomas C., et al. Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French national cohort. Pediatr Blood Cancer 2013, 60(11):1759-1765.
54. Patten D.K., Wani Z., Tolley N. Solitary Langerhans histiocytosis of the thyroid gland: a case report and literature review. Head Neck Pathol 2012, 6(2):279-289.
55. Xia C.X., Li R., Wang Z.H., et al. A rare cause of goiter: Langerhans cell histiocytosis of the thyroid. Endocr J 2012, 59(1):47-54.
56. Vergez S., Rouquette I., Ancey M., et al. Langerhans cell histiocytosis of the thyroid is a rare entity, but an association with a papillary thyroid carcinoma is often described. Endocr Pathol 2010, 21(4):274-276.
57. Jamaati H.R., Shadmehr M.B., Saidi B., et al. Langerhans cell histiocytosis of the lung and thyroid, co-existing with papillary thyroid cancer. Endocr Pathol 2009, 20(2):133-136.
58. Goldstein N., Layfield L.J. Thyromegaly secondary to simultaneous papillary carcinoma and histiocytosis X. Report of a case and review of the literature. Acta Cytol 1991, 35(4):422-426.
59. Burnett A., Carney D., Mukhopadhyay S., et al. Thyroid involvement with Langerhans cell histiocytosis in a 3-year-old male. Pediatr Blood Cancer 2008, 50(3):726-727.
60. Christie L.J., Evans A.T., Bray S.E., et al. Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon?. Hum Pathol 2006, 37(1):32-39.
61. Moschovi M., Adamaki M., Vlahopoulos S., et al. Synchronous and metachronous thyroid cancer in relation to Langerhans cell histiocytosis; involvement of V600E BRAF-mutation?. Pediatr Blood Cancer 2015, 62(1):173-174.
62. Tazi A., Soler P., Hance A.J. Adult pulmonary Langerhans' cell histiocytosis. Thorax 2000, 55(5):405-416.
63. Vassallo R., Ryu J.H., Colby T.V., et al. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2000, 342(26):1969-1978.
64. Arico M., Girschikofsky M., Genereau T., et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003, 39(16):2341-2348.
65. Baqir M., Vassallo R., Maldonado F., et al. Utility of bronchoscopy in pulmonary Langerhans cell histiocytosis. J Bronchology Interv Pulmonol 2013, 20(4):309-312.
66. Dacic S., Trusky C., Bakker A., et al. Genotypic analysis of pulmonary Langerhans cell histiocytosis. Hum Pathol 2003, 34(12):1345-1349.
67. Yousem S.A., Dacic S., Nikiforov Y.E., et al. Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest 2013, 143(6):1679-1684.
68. Roden A.C., Hu X., Kip S., et al. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol 2014, 38(4):548-551.
69. Dauriat G., Mal H., Thabut G., et al. Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis. Transplantation 2006, 81(5):746-750.
70. Arnaud L., Pierre I., Beigelman-Aubry C., et al. Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature. Arthritis Rheum 2010, 62(11):3504-3512.
71. Cartin-Ceba R., Golbin J.M., Yi E.S., et al. Intrathoracic manifestations of Rosai-Dorfman disease. Respir Med 2010, 104(9):1344-1349.
72. Park B.H., Son da H., Kim M.H., et al. Rosai-Dorfman disease: report of a case associated with IgG4-related sclerotic lesions. Korean J Pathol 2012, 46(6):583-586.
73. El-Kersh K., Perez R.L., Guardiola J. Pulmonary IgG4+ Rosai-Dorfman disease. BMJ Case Rep 2013, 2013.
74. Geissmann F., Thomas C., Emile J.F., et al. Digestive tract involvement in Langerhans cell histiocytosis. The French Langerhans Cell Histiocytosis Study Group. J Pediatr 1996, 129(6):836-845.
75. Singhi A.D., Montgomery E.A. Gastrointestinal tract Langerhans cell histiocytosis: a clinicopathologic study of 12 patients. Am J Surg Pathol 2011, 35(2):305-310.
76. Shima H., Takahashi T., Shimada H. Protein-losing enteropathy caused by gastrointestinal tract-involved Langerhans cell histiocytosis. Pediatrics 2010, 125(2):e426-e432.
77. Groisman G.M., Rosh J.R., Harpaz N. Langerhans cell histiocytosis of the stomach. A cause of granulomatous gastritis and gastric polyposis. Arch Pathol Lab Med 1994, 118(12):1232-1235.
78. Iwafuchi M., Watanabe H., Shiratsuka M. Primary benign histiocytosis X of the stomach. A report of a case showing spontaneous remission after 5 1/2 years. Am J Surg Pathol 1990, 14(5):489-496.
79. Detlefsen S., Fagerberg C.R., Ousager L.B., et al. Histiocytic disorders of the gastrointestinal tract. Hum Pathol 2013, 44(5):683-696.
80. Anders R.A., Keith J.N., Hart J. Rosai-Dorfman disease presenting in the gastrointestinal tract. Arch Pathol Lab Med 2003, 127(2):E74-E75.
81. Wimmer D.B., Ro J.Y., Lewis A., et al. Extranodal Rosai-Dorfman disease associated with increased numbers of immunoglobulin g4 plasma cells involving the colon: case report with literature review. Arch Pathol Lab Med 2013, 137(7):999-1004.
82. Morimoto A., Ishida Y., Suzuki N., et al. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan. Pediatr Blood Cancer 2010, 54(1):98-102.
83. Gadner H., Heitger A., Grois N., et al. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 1994, 23(2):72-80.
84. Grois N.G., Favara B.E., Mostbeck G.H., et al. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998, 12(2):287-305.
85. Grois N., Fahrner B., Arceci R.J., et al. Central nervous system disease in Langerhans cell histiocytosis. J Pediatr 2010, 156(6):873-881. 881.e1.
86. Hund E., Steiner H., Jansen O., et al. Treatment of cerebral Langerhans cell histiocytosis. J Neurol Sci 1999, 171(2):145-152.
87. Neurodegeneration in LCH, in press.
88. Meshkini A., Shahzadi S., Zali A., et al. Systemic juvenile xanthogranuloma with multiple central nervous system lesions. J Cancer Res Ther 2012, 8(2):311-313.
89. Deisch J.K., Patel R., Koral K., et al. Juvenile xanthogranulomas of the nervous system: a report of two cases and review of the literature. Neuropathology 2013, 33(1):39-46.
90. Paulus W., Kirchner T., Michaela M., et al. Histiocytic tumor of Meckel's cave. An intracranial equivalent of juvenile xanthogranuloma of the skin. Am J Surg Pathol 1992, 16(1):76-83.
91. Arnaud L., Hervier B., Neel A., et al. CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 2011, 117(10):2778-2782.
92. Jain R.S., Sannegowda R.B., Jain R., et al. Erdheim-Chester disease with isolated craniocerebral involvement. BMJ Case Rep 2013, 2013.
93. Adeleye A.O., Amir G., Fraifeld S., et al. Diagnosis and management of Rosai-Dorfman disease involving the central nervous system. Neurol Res 2010, 32(6):572-578.
94. Fukushima T., Yachi K., Ogino A., et al. Isolated intracranial Rosai-Dorfman disease without dural attachment: case report. Neurol Med Chir (Tokyo) 2011, 51(2):136-140.